Lawrence Bruno - 31 Dec 2022 Form 4 Insider Report for CORE LABORATORIES N V

Role: Chairman and CEO, Director
Signature: /s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 31 Dec 2022
Net transactions value: -$727,531
Form type: 4
Filing time: 04 Jan 2023, 15:46:41 UTC
Previous filing: 17 Feb 2022
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLB	Common Shares	Tax liability	$727,531	-35,892	-26%	$20.27^*	102,518	31 Dec 2022	Direct
transaction	CLB	Common Shares	Options Exercise	$0	+91,212	+193%	$0.000000	138,410	31 Dec 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLB	Performance Shares	Options Exercise	$0	-91,212	-100%	$0.000000^*	0	31 Dec 2022	Common Shares	91,212	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period.